Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
22 11 2019
Historique:
received: 12 11 2018
accepted: 26 10 2019
entrez: 24 11 2019
pubmed: 24 11 2019
medline: 4 11 2020
Statut: epublish

Résumé

Genome-wide association studies (GWAS) have successfully identified about 70 genomic loci associated with breast cancer. Owing to the complexity of linkage disequilibrium and environmental exposures in different populations, it is essential to perform regional GWAS for better risk prediction. This study aimed to investigate the genetic architecture and to assess common genetic risk model of breast cancer with 6,669 breast cancer patients and 21,930 female controls in the Japanese population. This GWAS identified 11 genomic loci that surpass genome-wide significance threshold of P < 5.0 × 10

Identifiants

pubmed: 31757997
doi: 10.1038/s41598-019-53654-9
pii: 10.1038/s41598-019-53654-9
pmc: PMC6874604
doi:

Substances chimiques

ALCAM protein, human 0
Antigens, CD 0
CLIC6 protein, human 0
Cell Adhesion Molecules, Neuronal 0
Chloride Channels 0
Core Binding Factor Alpha 2 Subunit 0
Fetal Proteins 0
RUNX1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17332

Références

Nat Genet. 2013 Apr;45(4):353-61, 361e1-2
pubmed: 23535729
Anticancer Res. 2010 Apr;30(4):1163-8
pubmed: 20530423
PLoS Genet. 2010 Jun 24;6(6):e1001002
pubmed: 20585626
Am J Hum Genet. 2004 Jun;74(6):1175-82
pubmed: 15122511
Cancer Res. 2013 May 1;73(9):2840-9
pubmed: 23447579
PLoS One. 2016 Nov 2;11(11):e0165559
pubmed: 27806084
Nature. 1995 Dec 21-28;378(6559):789-92
pubmed: 8524414
Carcinogenesis. 2014 May;35(5):1012-9
pubmed: 24325915
Am J Hum Genet. 2013 Oct 3;93(4):687-96
pubmed: 24094745
Breast Cancer Res Treat. 2011 Apr;126(3):717-27
pubmed: 20872241
Nat Genet. 2013 Apr;45(4):392-8, 398e1-2
pubmed: 23535733
Hum Mol Genet. 2016 Aug 1;25(15):3361-3371
pubmed: 27354352
Nat Genet. 2010 Oct;42(10):885-92
pubmed: 20852631
Fam Cancer. 2011 Jun;10(2):225-31
pubmed: 21365267
Nat Commun. 2014 Oct 20;5:5260
pubmed: 25327703
Jpn J Clin Oncol. 2014 Sep;44(9):777-82
pubmed: 25104790
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4340-5
pubmed: 18326623
Nat Genet. 2006 Aug;38(8):873-5
pubmed: 16832357
Hum Mol Genet. 2011 Dec 15;20(24):4991-9
pubmed: 21908515
Nat Genet. 2012 Jul 22;44(8):955-9
pubmed: 22820512
Oncology. 2012;82(6):305-12
pubmed: 22555284
PLoS One. 2013 Oct 15;8(10):e76463
pubmed: 24143190
Nat Genet. 2014 Aug;46(8):886-90
pubmed: 25038754
Gene Expr Patterns. 2011 Jun-Jul;11(5-6):327-33
pubmed: 21402173
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
Nat Genet. 1997 May;16(1):64-7
pubmed: 9140396
Nat Genet. 2012 Nov;44(11):1182-4
pubmed: 23001122
Mol Cancer. 2013 Sep 22;12(1):106
pubmed: 24053408
Nature. 2012 Jun 20;486(7403):405-9
pubmed: 22722202
Cancer Epidemiol Biomarkers Prev. 2014 Apr;23(4):658-69
pubmed: 24493630
Nat Commun. 2014 Aug 07;5:4577
pubmed: 25099679
Nat Genet. 2004 Apr;36(4):388-93
pubmed: 15052270
Nature. 2007 Jun 28;447(7148):1087-93
pubmed: 17529967
Annu Rev Genomics Hum Genet. 2009;10:387-406
pubmed: 19715440
Nat Genet. 2007 Jul;39(7):870-4
pubmed: 17529973
J Natl Cancer Inst. 2011 Mar 2;103(5):425-35
pubmed: 21263130
Breast Cancer Res. 2012 Mar 27;14(2):R56
pubmed: 22452962
Nucleic Acids Res. 2019 Jan 8;47(D1):D1005-D1012
pubmed: 30445434
Nat Commun. 2016 Apr 27;7:11375
pubmed: 27117709
Nat Genet. 2009 May;41(5):579-84
pubmed: 19330030
Nat Genet. 2009 Mar;41(3):324-8
pubmed: 19219042
Nat Genet. 2011 Oct 30;43(12):1210-4
pubmed: 22037553
J Hum Genet. 2012 Dec;57(12):766-71
pubmed: 22951594
Mol Cell Biol. 2002 Jun;22(11):3610-20
pubmed: 11997498
Nat Genet. 2007 Jul;39(7):865-9
pubmed: 17529974
Bioinformatics. 2005 Jan 15;21(2):263-5
pubmed: 15297300
Hum Mol Genet. 2016 Nov 1;25(21):4835-4846
pubmed: 28171663
Nat Commun. 2013;4:2464
pubmed: 24043118
Nat Rev Cancer. 2015 Oct;15(10):608-24
pubmed: 26383140
PLoS Genet. 2012;8(2):e1002532
pubmed: 22383897
Hum Mol Genet. 2008 Oct 15;17(R2):R122-8
pubmed: 18852200
PLoS Genet. 2010 Aug 12;6(8):
pubmed: 20714348
Hum Mol Genet. 2012 Dec 15;21(24):5373-84
pubmed: 22976474
Nat Genet. 2006 Aug;38(8):904-9
pubmed: 16862161
J Epidemiol. 2017 Mar;27(3S):S58-S64
pubmed: 28223083
Am J Hum Genet. 2008 Oct;83(4):445-56
pubmed: 18817904
Nat Genet. 2017 Jun;49(6):953-958
pubmed: 28416822
Science. 1994 Oct 7;266(5182):66-71
pubmed: 7545954
Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2523-31
pubmed: 25546839
Nature. 2017 Nov 2;551(7678):92-94
pubmed: 29059683
J Biol Chem. 2006 Feb 3;281(5):2750-6
pubmed: 16316993
Cancer. 2014 Nov 15;120(22):3446-56
pubmed: 24948110
PLoS Genet. 2010 Oct 28;6(10):e1001183
pubmed: 21060860
Carcinogenesis. 2016 Aug;37(8):741-750
pubmed: 27236187
Cancer Lett. 2013 May 28;332(2):133-40
pubmed: 20817393
Nat Genet. 2010 Jun;42(6):504-7
pubmed: 20453838

Auteurs

Siew-Kee Low (SK)

Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan. siewkee.low@jfcr.or.jp.
Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. siewkee.low@jfcr.or.jp.

Yoon Ming Chin (YM)

Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.

Hidemi Ito (H)

Division of Cancer Information and Control, Aichi Cancer Center Research Institute, Nagoya, Japan.
Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Keitaro Matsuo (K)

Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Chizu Tanikawa (C)

Laboratory of Genome Technology, Human Genome Center, The University of Tokyo, Tokyo, Japan.

Koichi Matsuda (K)

Graduate school of Frontier Sciences, The University of Tokyo, Tokyo, Japan.

Hiroko Saito (H)

Department of Genetic Diagnosis, The Cancer Institute of JFCR, Tokyo, Japan.

Mika Sakurai-Yageta (M)

Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.

Naoki Nakaya (N)

Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.

Atsushi Shimizu (A)

Iwate Tohoku Medical Megabank Organization, Iwate Medical University, Iwate, Japan.

Satoshi S Nishizuka (SS)

Iwate Tohoku Medical Megabank Organization, Iwate Medical University, Iwate, Japan.

Taiki Yamaji (T)

Division of Epidemiology, National Cancer Center, Tokyo, Japan.

Norie Sawada (N)

Division of Epidemiology, National Cancer Center, Tokyo, Japan.

Motoki Iwasaki (M)

Division of Epidemiology, National Cancer Center, Tokyo, Japan.

Shoichiro Tsugane (S)

Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.

Toshiro Takezaki (T)

Department of International Island and Community Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

Sadao Suzuki (S)

Department of Public Health, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Mariko Naito (M)

Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Department of Oral Epidemiology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Kenji Wakai (K)

Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Yoichiro Kamatani (Y)

Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Yukihide Momozawa (Y)

Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Yoshinori Murakami (Y)

Division of Molecular Pathology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Johji Inazawa (J)

Department of Molecular Cytogenetics, Tokyo Medical & Dental University, Tokyo, Japan.
Bioresource Research Center, Tokyo Medical & Dental University, Tokyo, Japan.

Yusuke Nakamura (Y)

Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.

Michiaki Kubo (M)

Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Toyomasa Katagiri (T)

Division of Genome Medicine, Institute for Genome Research, Tokushima University, Tokushima, Japan.

Yoshio Miki (Y)

Department of Genetic Diagnosis, The Cancer Institute of JFCR, Tokyo, Japan.
Department of Molecular Genetics, Medical Research Institute, Tokyo Medical & Dental University, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH